# MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)

> **NCT00122226** · PHASE4 · UNKNOWN · sponsor: **Amsterdam UMC, location VUmc** · enrollment: 50 (—)

## Conditions studied

- HIV Infections
- HIV-Associated Lipodystrophy Syndrome

## Interventions

- **DRUG:** Lopinavir/ritonavir + zidovudine + lamivudine
- **DRUG:** Lopinavir/ritonavir + nevirapine

## Key facts

- **NCT ID:** NCT00122226
- **Lead sponsor:** Amsterdam UMC, location VUmc
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-01
- **Primary completion:** —
- **Final completion:** 2008-07
- **Target enrollment:** 50 (—)
- **Last updated:** 2006-04-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00122226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00122226, "MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00122226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*